相关实验视频

Updated: Jun 22, 2025

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability

Published on: August 6, 2021

PON1,APOE和SDF-1基因多态和视网膜静脉封闭风险:一个案例对照研究

Antonios Ragkousis¹, Dimitrios Kazantzis¹, Ilias Georgalas²

¹2nd Department of Ophthalmology, Attikon University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece.

|June 27, 2024

概括

PON1 Q192R基因变异增加了视网膜静脉封闭 (RVO) 的风险. 这一发现表明,PON1 Q192R的R等位基因可能是RVO发展的重要风险因素.

科学领域:

眼科医生眼科眼科
遗传学是一个遗传学.
分子生物学分子生物学

背景情况:

视网膜静脉封闭 (RVO) 是一种复杂的疾病,除了血栓友爱之外,对遗传因素的研究有限.
氧化应激和炎症是已知的RVO病原体的贡献者.
研究与这些机制相关的特定基因多态性对于理解RVO风险至关重要.

研究的目的:

检查与炎症和氧化压力相关的基因多态 (APOE,PON1,SDF-1) 与希腊人群中RVO风险之间的关联.
识别可能使个体易患RVO的特定遗传变异.

主要方法:

一项涉及50名RVO患者和50名健康对照者的病例控制研究.
使用PCR-RFLP进行APOE,PON1 (rs854560,rs662) 和SDF-1 (rs1801157) 多态的基因定型.
统计分析包括后勤回归和哈普洛型分析,根据年龄,高血压和糖尿病进行调整.

主要成果:

PON1 Q192R多态 (rs662) 显示了与增加RVO风险的统计学上显著的关联.
携带PON1 192 R等位基因 (QR + RR基因型) 携带者与QQ同胞相比,RVO的风险明显更高 (OR=2.51,p=0.04;OR=2.83,p=0.042经调整后).
对于研究的APOE和SDF-1多态或PON1 L55M SNP,没有发现显著的关联.

结论:

PON1 Q192R多态的R等位基因与视网膜静脉封闭的风险增加有关.
这种遗传变异可能是RVO的危险因素,突出了氧化应激和炎症在疾病中的作用.
需要进一步的研究来阐明连接PON1 Q192R与RVO.的确切机制.

关键词:

在这里,APOEOE是APOE.一个叫PON1的人.这就是SDF-1的特点.遗传多形态的遗传多形态.这是一种炎症炎症炎症炎症.氧化应激是一种氧化应激.视网膜静脉闭塞视网膜静脉闭塞

更多相关视频

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization

Published on: August 11, 2023

相关概念视频

Genetic Lingo

Genetic Lingo

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...